ReShape Lifesciences Files Q1 2025 10-Q
Ticker: HIND · Form: 10-Q · Filed: May 20, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 10-Q |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
ReShape Lifesciences filed its Q1 2025 10-Q. Financials are in.
AI Summary
ReShape Lifesciences Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Obalon Therapeutics Inc., is based in San Clemente, CA. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on ReShape Lifesciences' financial health and operational performance for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a publicly traded company in the pharmaceutical sector, ReShape Lifesciences faces inherent market and regulatory risks, and the 10-Q provides details on its financial standing which could indicate financial health or distress.
Key Numbers
- 0.04 — Share Price (Used in Black-Scholes model calculations for options.)
- 800000 — Number of Shares (Likely related to options or share-based compensation calculations.)
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Filer of the 10-Q
- Obalon Therapeutics Inc. (company) — Former name of ReShape Lifesciences Inc.
- San Clemente, CA (location) — Business address of ReShape Lifesciences Inc.
- March 31, 2025 (date) — End of the reporting period for the 10-Q
- 20250331 (date) — Conformed period of report
FAQ
What is the primary business of ReShape Lifesciences Inc.?
ReShape Lifesciences Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as Obalon Therapeutics Inc.?
The date of the name change from Obalon Therapeutics Inc. to ReShape Lifesciences Inc. was February 20, 2008.
What is the fiscal year end for ReShape Lifesciences Inc.?
The fiscal year end for ReShape Lifesciences Inc. is December 31.
What is the SEC file number for ReShape Lifesciences Inc.?
The SEC file number for ReShape Lifesciences Inc. is 001-37897.
What specific financial metrics were used in the Black-Scholes model for options valuation as of February 8, 2023?
The filing indicates inputs such as Share Price, Risk-Free Interest Rate, Price Volatility, Expected Term, Expected Dividend Rate, and Exercise Price were used in the Black-Scholes model.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding ReShape Lifesciences Inc. (HIND).